MUMBAI: India's commerce ministry has hit back at reports by environmental lobby groups which have blamed the production methods of Indian drug companies as one of the main reasons for the rise of

With possible far-reaching consequences for the pharmaceutical industry in India, a report from a European agency campaigning for the environment has blamed manufactures in Hyderabad for growing an

Judgement of the Supreme Court of India in the matter of Union of India & Others Vs M/S. Cipla Ltd. & Others dated 21/10/2016 regarding retail pricing of drugs by Cipla. Supreme Court validates the notification dated 13th July, 1999 issued by the Central Government under Paragraph 7 of the Drugs (Prices Control) Order, 1995 prescribing the norms for conversion cost, packing charges and process loss of raw materials (other than packing materials in conversion) and packing and process loss of packing materials in packaging and allows the appeals filed by the Union of India.

Even after labouring for almost 90 years, researchers are yet to come out with an effective vaccine for the virus

As dengue cases show a steep increase, particularly in Delhi, the World Health Organisation (WHO) has recommended introducing dengue vaccine in highburden countries like India.

The popular notion that dengue-causing mosquito Aedes aegypti strikes only during morning hours is a myth.

INDORE: Highly polluting industries of the region that have been asked by Madhya Pradesh Pollution Control Board to install real time monitoring equipment to keep a check on emissions and effluents

KAKINADA: The villagers of Konaseema area, during a public hearing organised by the Andhra Pradesh Pollution Control Board (APPCB) at Kottapakala village in Tondangi mandal of East Godavari distric

The association between industry payments to physicians and prescribing rates of the brand-name medications that are being promoted is controversial. In the United States, industry payment data and Medicare prescribing records recently became publicly available.

Original Source

To understand the diversity and abundance of antibiotic resistance genes (ARGs) in pharmaceutical wastewater treatment bioreactors, the ARGs in sludge from two full-scale pharmaceutical wastewater treatment plants (PWWTPs) were investigated and compared with sludge samples from three sewage treatment plants (STPs) using metagenomic approach. The results showed that the ARG abundances in PWWTP sludge ranged from 54.7 to 585.0 ppm, which were higher than those in STP sludge (27.2 to 86.4 ppm).

Pages